Assuntos
Adjuvantes Imunológicos/farmacologia , Formação de Anticorpos/efeitos dos fármacos , Medula Óssea/química , Naloxona/farmacologia , Oligopeptídeos , Limiar da Dor/efeitos dos fármacos , Peptídeos/farmacologia , Animais , Feminino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBARESUMO
CBA mice were given a single Desferal dose (50 mg/kg). The mice received 3H-Thymidine 1 hour before they were killed. They were killed 1, 2, 6, or 9 hours after Desferal. Radiometry, and autoradiography were used to determine the level of DNA synthesis. Desferal was found to stimulate splenic 3H-incorporation 3 hours after drug injection and to increase the DNA-synthesizing cell fraction. In contrast, the agent inhibited 3H-incorporation in the bone marrow and thymus 9 hours after injection. This suppressive affect was accompanied by a decrease in the DNA-synthesizing cell fraction in these organs. In the thymus, there was a significant increase in the DNA-synthesizing cell fraction among lymphoblasts 1 and 3 hours following the administration of Desferal.
Assuntos
Medula Óssea/efeitos dos fármacos , Desferroxamina/farmacologia , Baço/efeitos dos fármacos , Timo/efeitos dos fármacos , Animais , Autorradiografia , Medula Óssea/metabolismo , Células da Medula Óssea , Divisão Celular/efeitos dos fármacos , DNA/biossíntese , DNA/efeitos dos fármacos , Masculino , Camundongos , Camundongos Endogâmicos CBA , Baço/citologia , Baço/metabolismo , Timo/citologia , Timo/metabolismo , Fatores de TempoAssuntos
Oligopeptídeos , Dor/fisiopatologia , Peptídeos/química , Sequência de Aminoácidos , Animais , Medula Óssea/efeitos dos fármacos , Células da Medula Óssea , Cromatografia Líquida de Alta Pressão , Feminino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Dados de Sequência Molecular , Peptídeos/fisiologia , Limiar SensorialRESUMO
In addition to the immunostimulating activity, bone marrow mediators, myelopeptides (MP) show the dose-dependent effect on the development of pain sensitivity in mice. When injected in nanogram amounts, MP induce hyperalgesia and 3-9 fold higher production of antibodies against SREC. When injected in milligram amounts, they exhibit hypoalgesic effect and no influence on antibody production. Immunostimulating effect in MP (mol, mass less than 1 KD, fraction 3) is accompanied with hypoalgesia. Bone marrow factors of mol. masses 40-150 KD (fraction 1) eluted at Sephadex G-25 gel-filtration before MP enhance the pain sensitivity tHreshold and show a potent immunodepressive effect. Thus the bone marrow factors are capable of exhibiting the opposite effects on the immune system in the pain control system that evidences the tight interrelation between these systems.
Assuntos
Adjuvantes Imunológicos/farmacologia , Analgésicos/farmacologia , Formação de Anticorpos , Medula Óssea/fisiologia , Oligopeptídeos , Dor/fisiopatologia , Peptídeos/farmacologia , Animais , Células Cultivadas , Feminino , Hibridização Genética , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Medição da Dor , Limiar SensorialRESUMO
It was found that vinblastine administered 48 hours after immunization of mice by sheep red cells produced a long-term (for up to 3 days) suppression of 3H-thymidine inclusion into lymphoid cells following a 8-12-hour latent period. This was accompanied with a complete elimination of humoral response of the draining lymph node and a five-fold decrease of the number of antibody-forming cells in the spleen.